March 22 (Reuters) - Pyxis Oncology Inc PYXS.O :
* PYXIS ONCOLOGY REPORTS FINANCIAL RESULTS FOR THE FISCAL
YEAR
ENDED DECEMBER 31, 2022, AND PROVIDES CORPORATE UPDATE
* PYXIS ONCOLOGY INC FY LOSS PER SHARE $3.65
* PYXIS ONCOLOGY INC - STRONG BALANCE SHEET GIVES A CASH
RUNWAY
INTO FIRST HALF OF 2025
* PYXIS ONCOLOGY INC - PRELIMINARY DATA FROM TWO PHASE 1
TRIALS
ANTICIPATED LATE 2023 TO EARLY 2024
Source text for Eikon: ID:nGNX7sdT4D
Further company coverage: PYXS.O
((Reuters.Briefs@thomsonreuters.com;))